XML 46 R40.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders' Equity - Additional Information (Details)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 23, 2025
shares
Jun. 18, 2025
shares
Aug. 29, 2024
Oct. 30, 2024
$ / shares
shares
Jan. 31, 2024
shares
Oct. 31, 2020
shares
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
Dec. 31, 2024
$ / shares
shares
Nov. 30, 2022
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common stock, issued             1,324,560   1,324,560   1,316,989  
Number of options, granted                 39,440      
Reverse stock split, conversion ratio     0.04                  
Restricted stock units, Granted             0   0      
Compensation expense recognized | $             $ 172,000 $ 891,000 $ 351,000 $ 2,250,000    
Restricted Stock Units                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Weighted- average grant-date fair value | $ / shares             $ 17.75   $ 17.75   $ 17.75  
Compensation expense recognized | $             $ 23,000,000 $ 47,000,000 $ 46,000,000 94,000,000    
Restricted Stock Units | One Year Milestone                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Stock options, vesting period                 1 year      
Vesting percentage                 33.00%      
Restricted Stock Units | Every Six Months Thereafter                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Stock options, vesting period                 6 months      
Vesting percentage                 17.00%      
Stock Options                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Weighted-average grant date fair value of stock options granted | $ / shares                 $ 4.24      
Intrinsic value per share of stock options | $ / shares                 $ 3.41   4.65  
Fair value of stock options vested | $                 $ 417,000 $ 2,202,000    
2020 Plan | Employee Stock Option                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Unrecognized compensation expense | $             $ 1,069,000   $ 1,069,000      
2020 Plan | Stock Options                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares available for future grant           0            
2020 Equity Incentive Plan                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares available for future grant             173,363   173,363      
2020 Equity Incentive Plan | Employee Stock Option                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Unrecognized compensation expense that is expected to be recognized over a weighted-average period                 2 years 4 months 24 days      
2020 Equity Incentive Plan | Employees                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Restricted stock units, Granted         34,200              
2020 Equity Incentive Plan | Time-Based Restricted Stock Units                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Weighted- average grant-date fair value | $ / shares                     $ 17.75  
2020 Equity Incentive Plan | Stock Options                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Stock options, vesting period           4 years            
Stock options, expiration period           10 years            
Percentage increase of number of shares of common stock issued and outstanding           5.00%            
Common Stock | 2022 Inducement Plan                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares available for future grant                       10,000
Shares issued                 0      
Bridge Medicines                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common stock, issued       62,594                
Series A Non Voting Convertible Preferred Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of preferred stock converted into common stock 2.201 1,000   1,000                
Series A Non Voting Convertible Preferred Stock | Common Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of preferred stock converted into common stock 2,201                      
Series A Non Voting Convertible Preferred Stock | Bridge Medicines                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Preferred stock, issued       160.562                
Preferred stock, par value | $ / shares       $ 0.00001